Hepatitis D screening: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) Created page with "{{Hepatitis D}} {{CMG}} {{EH}} ==References== {{reflist|2}} D Category:Viruses Category:Infectious disease {{WH}} {{WS}}" |
Varun Kumar (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{Hepatitis D}} | {{Hepatitis D}} | ||
{{CMG}} | {{CMG}}; {{AOEIC}} {{VK}} | ||
==Screening== | |||
Drug treatment programs should screen all patients for immunity to hepatitis B. Routine screening for hepatitis D is not indicated in persons who are HBsAg positive but asymptomatic. However, the following screening and prevention procedures may be appropriate: | |||
*Patients known to be HBsAg positive who have acute or chronic hepatitis may be tested for hepatitis D. The followup care and counseling, however, of a person co-infected with hepatitis D is not different from that of a person who is HBsAg positive. Therefore, knowing if the patient is co-infected with hepatitis D is of limited clinical significance. | |||
*Patients with acute hepatitis B who are not yet HBsAg positive, but are immunoglobulin M (IgM) hepatitis B core antibody (anti-HBc) positive, may be tested for HDV; however, again, the presence of HDV antibody will not alter the care or counseling of such a patient. | |||
*Patients who are HBsAg positive and/or HDV antibody positive should be advised not to share razors, toilet articles, or drinking and eating utensils. | |||
*Patients who are not already immune to hepatitis B virus should be vaccinated against the virus. | |||
*Screening is not necessary in the general population at no risk for HBV or HDV. | |||
==References== | ==References== | ||
| Line 9: | Line 16: | ||
[[Category:Viruses]] | [[Category:Viruses]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Disease]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 14:25, 16 March 2012
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D screening On the Web |
|
American Roentgen Ray Society Images of Hepatitis D screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
Screening
Drug treatment programs should screen all patients for immunity to hepatitis B. Routine screening for hepatitis D is not indicated in persons who are HBsAg positive but asymptomatic. However, the following screening and prevention procedures may be appropriate:
- Patients known to be HBsAg positive who have acute or chronic hepatitis may be tested for hepatitis D. The followup care and counseling, however, of a person co-infected with hepatitis D is not different from that of a person who is HBsAg positive. Therefore, knowing if the patient is co-infected with hepatitis D is of limited clinical significance.
- Patients with acute hepatitis B who are not yet HBsAg positive, but are immunoglobulin M (IgM) hepatitis B core antibody (anti-HBc) positive, may be tested for HDV; however, again, the presence of HDV antibody will not alter the care or counseling of such a patient.
- Patients who are HBsAg positive and/or HDV antibody positive should be advised not to share razors, toilet articles, or drinking and eating utensils.
- Patients who are not already immune to hepatitis B virus should be vaccinated against the virus.
- Screening is not necessary in the general population at no risk for HBV or HDV.